Skip to main content
Caplight Logo









PhaseV

PhaseV

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.phasevtrials.com/

Last Round

Series A

May 13, 2025

Total Funding Raised

$65M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

PhaseV is a healthcare technology company that provides an AI and machine learning-driven platform to optimize clinical development for biopharma sponsors and contract research organizations.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial optimizationcausal inferenceclinical trial designtrial simulationbiopharma AIclinical development softwarepredictive analyticsenrollment modelingcontract research organizationCROSaaS platformdrug developmenttrial success ratesAI in pharmaclinical trial tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PhaseV Comparables

Compare PhaseV with similar companies based on industry and business-model similarity.

PhaseV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QuantHealth
85%
Intelligencia AI
83%
Phesi
83%

PhaseV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 13, 2025
SeedOct 24, 2023

Key People

Founding team and executive leadership

Elad Berkman

CTO Co-Founder

Founding Team

Raviv Pryluk

CEO And Co-Founder

Founding Team

PhaseV Investors

Notable investors and investment history

PhaseV investors
InvestorRounds
Viola VenturesSeries A, Seed
ExorSeries A
LionBirdSeries A, Seed
Exor VenturesSeries A, Seed
Insight PartnersSeries A
AccelSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 333% to 7.1K.

  • Jul 23, 2026

    Grew 18% QoQ, from 56 to 66 employees.

PhaseV Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PhaseV Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PhaseV's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range62
Year Founded2023
Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?